Luisa Guidi

8PUBLICATIONS
16CO-AUTHORS
Nutritional epidemiologyCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Inter-organisational, extra-organisational and global information systemsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 12, 2023
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies.

Sebastiaan Ten Bokkel Huinink, Doranne Thomassen, Ewout W Steyerberg

|Feb 15, 2022
Incident Colorectal Cancer in Inflammatory Bowel Disease.

Benedetto Neri, Maria Lia Scribano, Alessandro Armuzzi

|May 17, 2021
Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches.

Giuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso

|Mar 06, 2021
Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases.

Giuseppe Privitera, Daniela Pugliese, Gian Ludovico Rapaccini

|Nov 19, 2020
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.

Lorenzo Bertani, Domenico Tricò, Daniela Pugliese

|May 23, 2020
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.

Franco Scaldaferri, Daniela Pugliese, Giuseppe Privitera

Pageof 2

Frequent Collaborators

3 joint publications

Daniela Pugliese

3 joint publications

Alessandro Armuzzi

2 joint publications

Stefano Festa

2 joint publications

Lorenzo Bertani